Daily FNArena News - Australia

A positive premium rate cycle should bring elevated revenue growth for general insurers but brokers note this is being offset by a loss of volume.

Investors remain cautious about Synlait Milk, which has many irons in the fire as it works on diversifying its food service strategy. Major customer a2 Milk is also critical to the outlook.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Australia’s real estate investment trusts, as a group, have outperformed the broader equity market but remain relatively subdued, largely because of the dominance of shopping centres.

Australia’s retail sector is at a low ebb. An eagerly-awaited improvement is expected to emerge over the next 6-12 months and brokers assess which stocks may benefit.

Negative factors continue to pile up for UK bank CYBG, amid unprecedented provisions for potential claimants in its FY19 accounts. Brokers rush to remove dividends from forecasts.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Ahead of an investor briefing, Incitec Pivot has downgraded guidance for FY19 and flagged a strategic review of its Australian fertiliser business.

Brokers decide new prudential capital controls may limit growth for banks and curb dividends.